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Background. Investigation of dynamics and regulation of the TGF-b signaling pathway is central to the understanding of
complex cellular processes such as growth, apoptosis, and differentiation. In this study, we aim at using systems biology
approach to provide dynamic analysis on this pathway. Methodology/Principal Findings. We proposed a constraint-based
modeling method to build a comprehensive mathematical model for the Smad dependent TGF-b signaling pathway by fitting
the experimental data and incorporating the qualitative constraints from the experimental analysis. The performance of the
model generated by constraint-based modeling method is significantly improved compared to the model obtained by only
fitting the quantitative data. The model agrees well with the experimental analysis of TGF-b pathway, such as the time course
of nuclear phosphorylated Smad, the subcellular location of Smad and signal response of Smad phosphorylation to different
doses of TGF-b. Conclusions/Significance. The simulation results indicate that the signal response to TGF-b is regulated by
the balance between clathrin dependent endocytosis and non-clathrin mediated endocytosis. This model is useful to be built
upon as new precise experimental data are emerging. The constraint-based modeling method can also be applied to
quantitative modeling of other signaling pathways.
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INTRODUCTION
The transforming growth factor b (TGF-b) superfamily consists of
TGF-bs, bone morphogenetic proteins (BMPs), activins and
related proteins. These proteins regulate numerous cellular
processes, such as cell proliferation, differentiation, apoptosis and
specification of developmental fate [1,2]. TGF-b initiates signaling
by forming a ligand-receptor complex with the type I and type II
receptors at cell surface. The activated receptor complex
propagates the signal inside by phosphorylating the receptor-
regulated Smad (R-Smad). Activated R-Smad then forms
a heteromeric complex with common mediated Smad (Co-Smad),
Smad4. These complexes accumulate in the nucleus and regulate
gene expression in a cell-type-specific manner through interactions
with transcription factors, coactivators and corepressors [3]. The
nuclear Smad complexes are then dephosphorylated by Smad
phosphatase [4]. Another important player is inhibitory Smad (I-
Smad), Smad7, which recruits Smurf to the TGF-b receptor
complex to facilitate the ubiquitin dependent degradation of
receptors [5]. Both R-Smad and Smad4 continuously shuttle
between the cytoplasm and nucleus in uninduced cells and also in
presence of TGF-b signal [6–8]. The receptors and activated
ligand-receptor complex are internalized through two distinct
endocytic routes, the clathrin-dependent endocytosis and the
caveolar lipid-raft mediated endocytosis [9,10]. Figure 1 schemat-
ically depicts the Smad dependent TGF-b signaling pathways.
Quantitative modeling studies of signaling pathways have been
successfully applied to understand complex cellular processes [11–
14]. Traditionally, the quantitative models are validated by fitting
western-blot data. Due to the complexity of the model and the
quality of the data, over-fitting is a common problem for
parameter estimation. When the model has many estimated
parameters and the corresponding data is a few, the over-fitting
problem might lead to some unwarranted conclusions because the
parameter set in the model might be a special domain of possible
parameter sets which can similarly fit the data well, but result in
different predictions. On the other hand, genome-scale constraint-
based models of metabolism have been constructed and used to
successfully interpret and predict cellular behavior [15]. Con-
straint-based modeling is an effective method to narrow the range
of the possible parameter space for quantitative models. However,
there is less attention to apply the constraint-based modeling for
the quantitative analysis of signaling pathways. Here, we proposed
a constraint-based modeling method to build a comprehensive
mathematical model for the Smad-dependent TGF-b signaling
pathway by fitting experimental data and incorporating the
qualitative constraints from the experimental analysis.
So far, several mathematical models have been proposed for the
TGF-b signaling pathways. Vilar et al. proposed a concise model
for the TGF-b receptor trafficking network [16]. On the other
hand, Clarke et al. [17] and Melke et al. [18] proposed the models
for the Smad nucleocytoplasmic shuttling and Smad phosphory-
lation response to the TGF-b signal without considering the
receptor trafficking steps. In this study, we established a compre-
hensive mathematical model for the TGF-b signaling pathway,
which includes the signal transduction, the receptor endocytosis,
the Smad nucleocytoplasmic shuttling, and the ligand induced
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well with the experimental analysis of TGF-b pathway, such as the
time course of nuclear phosphorylated Smad, the subcellular
location of Smad, and Smad phosphorylation response to different
concentrations of TGF-b. We employed the mathematical model
to study the dynamic relationship between receptor trafficking at
the cell surface and the activation of the phosphorylated Smad in
the nucleus. The simulation results indicate that the signal
response to TGF-b is regulated by the balance between clathrin
dependent endocytosis and non-clathrin mediated endocytosis.
MATERIALS AND METHODS
Mathematical model of the Smad dependent
TGF-b signaling pathway
We proposed here a comprehensive model for Smad dependent
TGF-b signaling pathway in mammalian cells, which includes
three modules: receptor trafficking and signaling; Smad nucleo-
cytoplasmic shuttling and signaling and I-Smad negative regula-
tion. In the module of receptor trafficking, the model takes into
account the following essential elements: (i) constitutive receptor
synthesis and degradation; (ii) receptor and ligand-receptor
complex trafficking by two distinct endocytic routes; (iii) the
distribution of receptors and ligand-receptor complex in different
pools, such as membrane surface, clathrin-coated pit, early
endosome and caveolar lipid-raft; (iv) the formation of activated
receptor complex induced by TGF-b. In the module of Smad
nucleocytoplasmic shuttling, the signal events we consider are (i)
Smad nucleocytoplasmic shuttling; (ii) Smad complex formation;
(iii) nuclear Smad complex dephosphorylation by nuclear
phosphatase. In the module of I-Smad negative regulation, the
negative feedback contributing to the ligand-induced degradation
of the receptors by I-Smad is simplified and modeled as a black
box from the nuclear phosphorylated Smad. We made the
following assumptions for the model:
(1) Experimental analyses indicate that TGF-b receptor traffick-
ing is not affected by TGF-b stimulation [9,10]. We assume
that the corresponding internalization and recycling rates for
type I receptor, type II receptor and activated ligand-receptors
are the same.
(2) Referring to the concise model of signal processing in the
TGF-b ligand-receptor network [16], we assume that the rate
of sequential formation of ligand-receptor complex is pro-
portional to the amount of ligand, type I receptor and type II
receptor.
Figure 1. Schematic representation of Smad dependent TGF-b signaling pathway. Detailed information about this pathway is described in the text.
doi:10.1371/journal.pone.0000936.g001
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PLoS ONE | www.plosone.org 2 September 2007 | Issue 9 | e936(3) The experimental data shown by Lin, et al. indicate that the
variation of total amount of Smad is small [4]. We assume
that the total amount of Smad is constant. Therefore, the
production and degradation of Smad are not considered in
this model.
(4) Previous experimental analyses suggest that I-Smad/Smurf
complex targets the lipid-raft-bound receptor for degradation
which leads to the ligand-induced negative feedback [5,9]. We
assume that the rate of ligand-induced degradation of
receptors is proportional to the amount of nuclear phos-
hporylated Smad and the receptor complex in caveolar lipid-
raft.
In order to compare with the published data, we used Smad2
denoting R-Smad. We used the law of mass-action to describe the
rate of signal transduction steps. The time-dependent changes of
the concentrations of the signaling proteins and protein complexes
are determined by the following system of differential equations:
d½T1RSurf 
dt
~vT1R{kiCave½T1RSurf zkrCave½T1RCave {
kiEE½T1RSurf zkrEE½T1REE zkrCave½LRCCave {
kLRC½TGFb ½T1RSurf ½T2RSurf 
ð1Þ
d½T1RCave 
dt
~kiCave½T1RSurf {krCave½T1RCave ð 2Þ
d½T1REE 
dt
~kiEE½T1RSurf {krEE½T1REE {kT1R
deg ½T1REE ð 3Þ
d½T2RSurf 
dt
~vT2R{kiCave½T2RSurf zkrCave½T2RCave {
kiEE½T2RSurf zkrEE½T2REE zkrCave½LRCCave {
kLRC½TGFb ½T1RSurf ½T2RSurf 
ð4Þ
d½T2RCave 
dt
~kiCave½T2RSurf {krCave½T2RCave ð 5Þ
d½T2REE 
dt
~kiEE½T2RSurf {krEE½T2REE {kT2R
deg ½T2REE ð 6Þ
d½LRCSurf 
dt
~kLRC½TGFb ½T1RSurf ½T2RSurf {
kiCave½LRCSurf {kiEE½LRCSurf 
ð7Þ
d½LRCCave 
dt
~kiCave½LRCSurf {krCave½LRCCave {
klid½LRCCave ½Smads Complexnuc 
ð8Þ
d½LRCEE 
dt
~kiEE½LRCSurf {krEE½LRCEE {kcd½LRCEE ð 9Þ
d½Smad2cyt 
dt
~{kSmad2
imp ½Smad2cyt z
kSmad2
exp ½Smad2nuc Vnuc
Vcyt
{kSmads Complex½Smad2cyt ½Smad4cyt ½LRCEE 
ð10Þ
d½Smad2nuc 
dt
~
kSmad2
imp ½Smad2cyt Vcyt
Vnuc
{kSmad2
exp ½Smad2nuc 
zk
Smads Complex
diss ½Smads Complexnuc 
ð11Þ
d½Smad4cyt 
dt
~{kSmad4
imp ½Smad4cyt z
kSmad4
exp ½Smad4nuc Vnuc
Vcyt
{kSmads Complex½Smad2cyt ½Smad4cyt ½LRCEE 
ð12Þ
d½Smad4nuc 
dt
~
kSmad4
imp ½Smad4cyt Vcyt
Vnuc
{kSmad4
exp ½Smad4nuc 
zk
Smads Complex
diss ½Smads Complexnuc 
ð13Þ
d½Smads Complexcyt 
dt
~kSmads Complex½Smad2cyt ½Smad4cyt 
½LRCEE zk
Smads Complex
imp ½Smads Complexcyt 
ð14Þ
d½Smads Complexnuc 
dt
~
k
Smads Complex
imp ½Smads Complexcyt Vcyt
Vnuc
{k
Smads Complex
diss ½Smads Complexnuc 
ð15Þ
d½TGFb 
dt
~(krCave½LRCCave zkrEE½T2REE {
kLRC½TGFb ½T1Rsurf ½T2Rsurf )Vcyt=Vextra
ð16Þ
The model is composed of an ordinary differential equations
system with 16 state variables and 20 parameters. The values and
the corresponding biological meaning of the parameters are listed
in Table 1. The initial conditions and the biological meaning of
the variables are listed in Table 2.
Derivation of the parameter values
In order to keep the consistency of the parameter values, we
derived the parameter values from experimental analysis in
epithelial cells. In particularly, most of the data used in this study
is from experimental analysis of HaCaT (Human keratinocyte cell
line) cells. The rational guided the derivation of relative parameter
values is described in the following:
N Parameters for the volume ratio of different compart-
ments: The model distinguishes the different compartments of
extracellular medium, cytoplasm and nucleus where the
Modeling of TGF-b Pathway
PLoS ONE | www.plosone.org 3 September 2007 | Issue 9 | e936signaling steps take place. The average cytoplasimc/nuclear
volume ratio (
Vcyt
Vnuc
) was measured as about 3 in reference [8].
The volume of HaCaT cell is estimated as about 1.4610
212
Liter [19,20], therefore, we can derive the volume of cytoplasm
and nucleus are 1.05610
212 Liter and 3.5610
213 Liter,
respectively. A typical cell culture experiment would have a cell
density of 1.0610
6 cells/ml. The average extracellular medium
volume per cell (Vextra) is about 1.0610
29 Liter. Hence, the
volume ratio of cytoplasm to extracellular medium (
Vcyt
Vextra
)i s
set to a value of 0.001.
Table 1. Parameter values in the model
..................................................................................................................................................
Parameter symbol Biological meaning Value Unit Reference
vTIR type I receptor production rate constant 0.0103 nM/min estimated
vT2R type II receptor production rate constant 0.02869 nM/min estimated
kiEE internalization rate constant of receptor from cell surface to early endosome 0.33 min
21 [9,16]
krEE recycling rate constant of receptor from early endosome to cell surface 0.033 min
21 [9,16]
kiCave internalization rate constant of receptor from cell surface to caveolar lipid-raft 0.33 min
21 [9,16]
krCave recycling rate constant of receptor from caveolar lipid-raft to cell surface 0.03742 min
21 estimated
kcd constitutive degradation rate constant for ligand-receptor complex in early endosome 0.005 min
21 [9]
kLRC ligand-receptor complex formation rate constant from TGF-b and receptors 2197 nM
22min
21 estimated
klid ligand induced degradation rate constant for ligand-receptor complex in caveolar lipid-raft 0.02609 min
21 estimated
k
T1R
deg constitutive degradation rate constant for type I receptor in early endosome 0.005 min
21 [21]
k
T2R
deg constitutive degradation rate constant for type II receptor in early endosome 0.025 min
21 [21]
k
Smad2
imp nuclear import rate constant for Smad2 0.16 min
21 [8]
k
Smad2
exp nuclear export rate constant for Smad2 1 min
21 [8]
k
Smad4
imp nuclear import rate constant for Smad4 0.08 min
21 [8]
k
Smad4
exp nuclear export rate constant for Smad4 0.5 min
21 [8]
kSmads_Complex formation rate constant for the phosphorylated Smad complex 6.85610
25 nM
22min
21 estimated
k
Smads_Complex
imp nuclear import rate constant for the phosphorylated Smad complex 0.16 min
21 [8,22]
k
Smads_Complex
diss dissociation rate constant for the nuclear phosphorylated Smad complex 0.1174 min
21 estimated
Vcyt/Vnuc ratio of cytoplasmic to nuclear volume 3.0 3.0 [8]
Vcyt/Vextra ratio of cytoplasmic volume to the average extracellular medium volume per cell 0.001 0.001 [19,20]
doi:10.1371/journal.pone.0000936.t001
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Table 2. Initial conditions of state variables (proteins) in the model
..................................................................................................................................................
Variable symbol Biological meaning Value of the initial condition
T1Rsurf type I receptor at cell surface 0.237
T1RCave type I receptor in caveolar lipid-raft 2.092
T1REE type I receptor in early endosome 2.06
T2Rsurf type II receptor at cell surface 0.202
T2RCave type II receptor in caveolar lipid-raft 1.778
T2REE type II receptor in early endosome 1.148
LRCSurf ligand-receptor complex at cell surface 0
LRCCave ligand-receptor complex in caveolar lipid-raft 0
LRCEE ligand-receptor complex in early endosome 0
Smad2cyt Smad2 in the cytoplasm 492.61
Smad2nuc Smad2 in the nucleus 236.45
Smad4cyt Smad4 in the cytoplasm 1149.4
Smad4nuc Smad4 in the nucleus 551.72
Smads_Complexcyt phosphorylated Smad complex in the cytoplasm 0
Smads_Complexnuc phosphorylated Smad complex in the nucleus 0
TGFb TGF-b in the extracellular medium 0.08 nM for 2 ng/ml
The initial conditions of the variables are set as the steady state concentration of the corresponding proteins in the uninduced cell which are derived from the
parameter values described in Table 1.
doi:10.1371/journal.pone.0000936.t002
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PLoS ONE | www.plosone.org 4 September 2007 | Issue 9 | e936N Rate constant of receptor constitutive degradation:
Pervious experimental data indicate that the type II receptor
has a half-life of about 1 hr, whereas type I receptors are more
stable, with a half-life of about 4–6 hr [21]. The receptors are
constitutively degraded from early endosomes and about 50%
percent of initial labeled receptors locate in early endosome [9].
Rescaling the degradation rate of the total receptors to the early
endosome receptors results in constitutive degradation rate
constant of type I receptor (k
T1R
deg ) and type II receptor (k
T2R
deg )
with value of 0.005 min
21 (
{ln0:5
300min|0:5
) and 0.025 min
21
(
{ln0:5
60min|0:5
), respectively. On the other hand, Figure 3 of
reference [9] shows that only 30% of the initial labeled receptor
complex remain in the cell after 8 h when the caveolar
endocytosis is inhibited. Based on this information, we can
derive the constitutive degradation rate constant of ligand-
receptor complex (kcd) is 0.005 min
21 (
{ln0:3
480min|0:5
).
N Rate constant of receptor internalization and recyc-
ling:V i l a ret al. derived the rate constant of receptor
internalization and recycling based on the experimental
observations [16]. On the other hand, reference [9] indicate
that receptors are internalized through clathrin and non-
clathrin independent endocytosis route with similar rates.
Therefore, we choose the internalization rate constant of
receptors (kiEE and kiCave) with the value of 0.33 min
21 which is
estimated in reference [16]. The recycling rate constant (krEE)
for the receptors recycled from early endosome back to the cell
surface is set to a value of 0.033 min
21, which is derived in
reference [16].
N Rate constant for Smad nuclear import and export:
The nuclear import rate of Smad2 (k
Smad2
imp ) was experimentally
measured with the value of 0.16 min
21 in reference [8].
Reference [8] also measured that the ratio of mean nuclear
fluorescence to mean cytoplasmic fluorescence (R) of Smad2 in
uninduced cells is about 0.5. The R ratio of Smad2 is
equivalent to the ratio of nuclear to cytoplasmic Smad2
concentrations. We can derive R~
kSmad2
imp :Vcyt
kSmad2
exp :Vnuc
according to
equation (31). Therefore, the value for the nuclear export rate
constant (k
Smad2
exp ) in our model is about 1 min
21
(kSmad2
exp ~
kSmad2
imp
R
: Vcyt
Vnuc
). On the other hand, Figure 5A of
reference [8] also shows that the nuclear export rate of
Smad4 is about half of the nuclear export rate of
Smad2. Hence, the nuclear export rate constant of
Smad4 (k
Smad4
exp ) is 0.5 min
21. Since the R ratio of Smad4 is
measured with a value of about 0.5 [8], we can derive the
nuclear import rate constant of Smad4 (k
Smad4
imp ) a value of
0.08 min
21.
N Nuclear import rate constant of phosphorylated
Smad: Figure 3 of reference [22] shows that nuclear import
rate between phoshporylated and unphosphorylated Smad2 is
similar. Therefore, we set the import rate constant for the
phosphorylated Smad complex (k
Smads_Complex
imp ) to the same value
as the import rate constant for unphosphorylated Smad2,
which is 0.16 min
21.
There are 7 unknown parameter values in the model that are
required to be estimated, i.e. vT1R, vT2R, krCave, kLRC, klid,
kSmads_Complex and k
Smads_Complex
diss .
Steady state analysis of the model for the
uninduced cell
We performed steady state analysis of the model for the uninduced
cell without TGF-b stimulation. When there is no TGF-b present to
the cells, the concentrations of the ligand-receptor complex and
phosphorylated Smad complex are assumed to be zero.
For type I receptor, we can derive the following algebraic
equations for the steady state of the unindcued cell:
d½T1RSurf ss
dt
~vT1R{kiCave½T1RSurf sszkrCave½T1RCave ss
{kiEE½T1RSurf sszkrEE½T1REE ss~0
ð17Þ
d½T1RCave ss
dt
~kiCave½T1RSurf ss{krCave½T1RCave ss~0 ð18Þ
d½T1REE ss
dt
~kiEE½T1RSurf ss{krEE½T1REE ss
{kT1R
deg ½T1REE ss~0
ð19Þ
The steady state concentrations of type I receptor at cell surface, in
the lipid-raft and in the early endosome, obtained by solving the
systems of algebraic equations (17–19), are
½T1RSurf ss~
vT1R(krEEzkT1R
deg )
kT1R
deg :kiEE
ð20Þ
½T1RCave ss~
vT1R(krEEzkT1R
deg )kiCave
kT1R
deg :kiEE:krCave
ð21Þ
½T1REE ss~
vT1R
kT1R
deg
ð22Þ
The steady state concentrations of type II receptor at cell surface,
in the lipid-raft and in the early endosome are
½T2RSurf ss~
vT2R(krEEzkT2R
deg )
kT2R
deg :kiEE
ð23Þ
½T2RCave ss~
vT2R(krEEzkT2R
deg )kiCave
kT2R
deg :kiEE:krCave
ð24Þ
½T2REE ss~
vT2R
kT2R
deg
ð25Þ
For the Smad2 in the cytoplasm and nucleus, the following
algebraic equations should be satisfied for the steady state of the
unindcued cell:
d½Smad2cyt ss
dt
~{kSmad2
imp ½Smad2cyt ssz
kSmad2
exp ½Smad2nuc ssVnuc
Vcyt
~0
ð26Þ
Modeling of TGF-b Pathway
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dt
~
kSmad2
imp ½Smad2cyt ssVcyt
Vnuc
{
kSmad2
exp ½Smad2nuc ss~0
ð27Þ
Because the total amount of Smad2 is a constant, mass
conservation reads:
Ntotal
Smad2~Vcyt½Smad2cyt sszVnuc½Smad2nuc ss ð28Þ
Solving the algebraic equations (26–28) yields the steady state
concentrations of cytoplasmic and nuclear Smad2 in the
uninduced cell as following:
½Smad2cyt ss~
Ntotal
Smad2:kSmad2
exp
Vcyt(kSmad2
imp zkSmad2
exp )
ð29Þ
½Smad2nuc ss~
Ntotal
Smad2:kSmad2
imp
Vnuc(kSmad2
imp zkSmad2
exp )
ð30Þ
The ratio of nuclear to cytoplasmic Smad2 concentration
corresponds to the ratio of mean nuclear fluorescence to mean
cytoplasmic fluorescence (R) of Smad2, according to equations
(29–30), which is
R~
½Smad2nuc ss
½Smad2cyt ss
~
kSmad2
imp :Vcyt
kSmad2
exp :Vnuc
ð31Þ
The steady state concentrations of cytoplasmic and nuclear Smad4
in the uninduced cell are
½Smad4cyt ss~
Ntotal
Smad4:kSmad4
exp
Vcyt(kSmad4
imp zkSmad4
exp )
ð32Þ
½Smad4nuc ss~
Ntotal
Smad4:kSmad4
imp
Vnuc(kSmad4
imp zkSmad4
exp )
ð33Þ
The total amount of Smad2 (N
total
Smad2) and Smad4 (N
total
Smad4) are
estimated to be 6610
219 mol per cell and 1.4610
218 mol per cell
in HaCaT cells, which corresponds to about 3.6610
5 and 8.4610
5
molecules per cell, respectively [23].
Without the treatment of TGF-b, the concentrations of
signaling proteins will arrive at steady state balancing protein
production, degradation, receptor endocytosis and Smad protein
nucleocytoplasmic shuttling. We set the initial concentrations of
the signaling proteins as their steady state values before TGF-b is
added.
Parameter estimation by constraint-based modeling
The parameter estimation for the 7 unknown values of rate
constants was done using a modified version of the tool SBML-
PET [24], which incorporates stochastic ranking evolution strategy
(SRES) for parameter estimation jobs. SRES is an evolutionary
optimization algorithm that uses stochastic ranking as the
constraint handling technique [25]. The objective of the para-
meter estimation is to find the most feasible parameters in the
model that reproduce the quantitative experimental data for the
TGF-b signaling pathway. At the same time, the model with the
estimated parameters should satisfy some qualitative experimental
observation of this pathway. Therefore, the corresponding quanti-
tative time course data is used in the objective function definition
and the qualitative data is coded as constraints during the optimi-
zation process. We used two time courses of Smad phosphoryla-
tion for parameter estimation:
(1) The quantitative western blot data reported in Figure 1A in
Lin et al. [4] gives us the time course of Smad2 in the whole
HaCaT cell extract in the presence of continuous TGF-
b stimulation for 24 hours. We normalized the data to its
maximum value which gives us the dynamic change of the
protein. We also normalized corresponding simulation data to
its maximum value so that we can compare the experimental
data and the simulation data.
(2) The quantitative western blot data reported in Figure 1C in
Lin et al. [4] gives us the time course of Smad2 phosphor-
ylation under a different condition. TGF-b (2 ng/ml) is added
at first 30 minutes, then washed out and type I receptor kinase
inhibitor SB431542 is added to terminate the signal.
Other qualitative information from the literatures is used as
constraints encoded within SRES method.
(1) The number of total receptors per cell falls into the range of
1000 to 100000 per cell according to the distribution of
TGF-b receptors in a wide spectrum of cell types reported in
Wakefield et al. [26].
(2) Experimental results of receptor distribution at the cell
surface, in the early endosomes and caveolin-positive vesicles
indicate that about 40,50% percent of total receptors are
located in the early endosomes [9,10]. We set a constraint for
the distribution of receptors, that the about at least 30% and
at maximum 60% of receptors locate in the early endosome.
(3) Schmierer et al. quantified the Smad redistribution in HaCaT
cells upon 2 ng/ml TGF-b with photobleaching experiments
using EGFP-Smad (enhanced green fluorescent protein)
fusions [8]. The study indicates that the ratio of nuclear to
cytoplasmic Smad2 concentrations is about 2.5 after 1 hour
TGF-b treatment. After TGF-b stimulus, about 80% of the
Smad2 in the nuclues is phosphorylated or complexed. We set
constraints for the corresponding Smad2 distribution: the
ratio of nuclear to cytoplasmic Smad2 concentrations should
be in the range of 1.5,3.5 and 60%,90% of the Smad2 in
the nucleus is phosphorylated or complexed after 1 hour
TGF-b treatment.
(4) Previous experimental data indicate that 0.5 ng/ml (20 pM)
of TGF-b is sufficient to yield a maximal response of Smad
phosphorylation after 1 hour TGF-b treatment [27,28]. We
encode this information as a constraint that the ratio of Smad
phosphorylation level with the dose of 0.5 ng/ml to that with
the dose of 2 ng/ml TGF-b at 60th minute should be larger
than 0.9 and smaller than 1.1.
RESULTS AND DISCUSSION
Comparison of kinetic simulation with experimental
analysis
We first check whether the model obtained by constraint-based
modeling method can reproduce the experimental data used for
Modeling of TGF-b Pathway
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quality of ‘‘in-sample fit’’ (how good is the model fitting the data
used for parameter estimation). Experiments reported that the
signal would peak at about 30–60 min after TGF-b addition. The
result shown in Figure 2A indicates that the simulated time courses
of Smad2 phosphorylation agree well with the experimental data
[4]. The model is also able to reproduce the experimental
observation that the treatment with type I receptor kinase inhibitor
SB431542 will cause rapid decrease of the nuclear phosphorylated
Smad2 level [4,29] (Figure 2B). Taken these simulation results
together, the model has good ‘‘in-sample fit’’ for the data.
We next asked whether the model has a good match to other
experimental data that were not used for parameter estimation.
This test can be regarded as ‘‘out-sample fit’’ or model validation.
The result shown in Figure 2C indicates that the simulated time
courses of nuclear phosphorylated Smad2 agree well with the
experimental data [29]. As a further test, we calculated the
subcellular location of Smad2 from the simulation result of the
model. The results are in agreement with previous reports that
TGF-b causes a change in the overall Smad2 distribution from
predominantly cytoplasmic to predominantly nuclear [6–8,29].
After TGF-b treatment, Smad2 proteins are rapidly accumulated
in the nucleus and then return to the cytoplasm (Figure 2D).
Finally, we tested whether the model can predict well the signal
response to different dose of TGF-b. Previous experimental data
indicate that the response of Smad phosphorylation after 1 hour
TGF-b treatment will be saturated when the concentration of
TGF-b is larger than 0.5 ng/ml [27,28]. The model successfully
predicts the dose-response of Smad phosphorylation upon
different concentrations of TGF-b (Figure 3).
Model performance is significantly improved by
constraint-based modeling
We compared the performance of the model generated by
constraint-based modeling method and that of the model obtained
Figure 2. Comparison of experimental analysis and simulation results from the model obtained by constraint-based modeling method. (A–B) for
‘‘in-sample fit’’. (C–D) for ‘‘out-sample fit’’. (A) Comparison of the model time course and experimental time course of Smad2 phosphorylation with
24 hours TGF-b treatment. The experimental data is normalized from Figure 1A in Lin et al. [4]. (B) Effect of type I receptor kinase inhibitor SB431542.
Cells were treated with TGF-b for 30 minutes, then were washed out TGF-b at 30th minute and added SB431542 to prevent rephosphorylation of
Smad2. The experimental data is normalized from Figure 1C in Lin et al. [4]. (C) Comparison of the model time course with an experimental time
course of nuclear phosphorylated Smad2 after TGF-b treatment (80 pM, 2 ng/ml). The western-blot data reported by Inman et al. (Fig. 1A, top panel)
is quantified with Scion Image software [29]. (D) Subcellular location of Smad2 after TGF-b treatment (80 pM). The concentrations shown here refer to
the local concentrations in cytoplasm and nucleus.
doi:10.1371/journal.pone.0000936.g002
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experimental data and simulation results from the model obtained
by only fitting the time course data. The results shown in Figure 4
indicate that the model has been over-fitted to the data used for
parameter estimation (Figure 4A–4B), but it has bad predictions
for the data that are not used for parameter estimation. For
example, experimental evidence shows that the response of Smad
phosphorylation after 1 hour TGF-b treatment will be saturated
when the concentration of TGF-b is larger than 0.5 ng/ml
[27,28]. However, the predicted time course of phosphorylated
Smad2 in the model, obtained by only fitting the time course data,
is not saturated even for a very high dose of TGF-b (10 ng/ml),
which contradicts the experimental results (Figure 4C).
On the other hand, we compared the possible variation of
parameter sets of the models by these two different methods. For
each method, we independently generated 1000 parameter sets
which make the model have similar goodness of fitting the time
course data of Smad phosphorylation (Table S1 and Table S2).
According to the statistical result for the parameter sets shown in
Table 3, the ranges of the variation for the 7 estimated parameter
values are significantly narrowed by constraint-based modeling
method.
Previous modeling studies of TGF-b signaling pathway indicate
that the Smad phosphorylation response to TGF-b is robust to
a large variation of some parameters [17,18]. The large variations
in the estimated parameter sets are usually caused by two reasons.
The data quality is the main reason for the large variation of
parameter sets obtained by only fitting the time course data. When
we fit the western-blot data, we actually fit the scaled data.
However, the parameter for the scaled coefficient is unknown,
which can vary in a large range if we only fitting the scaled time
course data without considering other qualitative constraints.
Another reason comes from the insensitivity of some parameters to
the signal response. For example, the sensitivities of the parameters
kLRC, vT2R and klid are very small (Figure 5), which means the
output of the model (Smad phosphorylation level) is robust to the
variation of these insensitive parameters.
Sensitivity analysis of the model
We next systematically investigated the sensitivity of all the rate
constants and found those whose perturbation the pathway is most
sensitive or most robust against. Response sensitivities were used
for quantifying the effects of all the rate constants on the
concentration of signaling proteins. In this model, we regard
nuclear phosphorylated Smad complex (nuclear phosphorylated
Smad2) as the readout of the signal in this pathway because
experimental results indicate that nuclear phosphorylated Smad
complex acts as transcription factor to induce the expression of
many genes [1,3]. We determined the sensitivity of the integral
concentrations of the nuclear phosphorylated Smad complex from
the beginning of the TGF-b activation to the end of the simulation
time (8 hours). The definition of response sensitivity for nuclear
phosphorylated Smad is as following:
RSmads Complex n
pi ~
L(Smads Complex n)
Smads Complex n
Lpi
pi
ð34Þ
As shown in Figure 5, we can divide the parameters into three
groups: positive control, negative control and almost no control to
the changes of nuclear Smad complex. The strong positive and
negative control groups belong to the reactions participating
phosphorylation of Smad, receptor endocytosis, type I receptor
production. The most negative control on the concentration of
nuclear Smad complex is the rate constants corresponding to the
dephosphorylation of nuclear Smad complex, which implies
Figure 3. Effects on Smad2 phosphorylation by different doses of
TGF-b.
doi:10.1371/journal.pone.0000936.g003
Figure 4. Comparison of experimental analysis and simulation results from the model obtained by only fitting the time course data. (A–B) The
model has been over-fitted for ‘‘in-sample fit’’. (C) The model has a bad prediction for ‘‘out-sample fit’’. (A) Comparison of the model time course and
experimental time course of Smad2 phosphorylation with 24 hours TGF-b treatment. Experimental data is the same as described in Figure 2A. (B)
Effect of type I receptor kinase inhibitor SB431542. Experimental data is the same as described in Figure 2B. (C) Effects on Smad2 phosphorylation by
different doses of TGF-b.
doi:10.1371/journal.pone.0000936.g004
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the nuclear phosphorylated Smad level. Finally, we want to point
out that all these analyses are based on small perturbations of
relative parameters according to the definition of response
coefficient.
The regulation of the signal: balance between
clathrin dependent endocytosis and non-clathrin
mediated endocytosis
In the experimental studies, potassium depletion can be used to
interfere with clathrin-dependent trafficking of receptors, which
can inhibit the TGF-b signal [9,30]. On the other hand, nystatin
treatment causes the inhibition of the non-clathrin endocytosis
pathway [9]. The simulation analysis of the model indicates that
the inhibition of clathrin dependent endocytosis causes a transient
response of Smad2 phosphorylation (Figure 6A). The simulation
result also shows that inhibition of non-clathrin dependent
endocytosis increases TGF-b signal amplitude, which produces
a prolonged signal (Figure 6C).
What will happen if both clathrin dependent and non-clathrin
dependent endocytosis are inhibited? The simulation results
indicate that the key quantity is the ratio of clathrin to non-
clathrin dependent endocytosis rate. A transient response of
Smad2 phosphorylation appears upon the combination of a strong
inhibition of clathrin dependent endocytosis and a weak inhibition
of non-clathrin mediated endocytosis, which corresponds to a low
ratio of clathrin to non-clathrin dependent endocytosis rate
(Figure 6D). Furthermore, when both clathrin dependent
endocytosis and non-clathrin dependent endocytosis are equally
inhibited (a medium ratio of clathrin to non-clathrin dependent
endocytosis rate), the signal response of Smad2 phosphorylation is
Table 3. Range of the variation for the estimated parameters in the 1000 parameter sets
..................................................................................................................................................
Obtained by constraint-based modeling method Obtained by only fitting the time course data
Parameter Minimum value Maximum value
Range of variation:
log10(max/min) Minimum value Maximum value
Range of variation:
log10(max/min)
vT1R 0.007482 0.02712 0.55927 0.001309 0.5195 2.5986
vT2R 0.02167 0.1101 0.70593 0.008435 4.874 2.7618
krCave 0.03737 0.04243 0.05515 0.001571 0.04571 1.4638
kLRC 1305 86850 1.8232 0.1088 6.835e+006 7.7981
klid 0.001011 0.9774 2.9853 1.383e-005 0.9988 4.8587
kSmads_Complex 2.283610
25 9.694610
25 0.628 3.152e-007 0.000203 2.8089
k
Smads_Complex
diss 0.09519 0.1298 0.13468 0.07243 0.9985 1.1394
The values of the 1000 parameter sets obtained by each method are available in Table S1 and Table S2
doi:10.1371/journal.pone.0000936.t003
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Figure 5. Sensitivity analysis of the rate constants on nuclear Smad phosphorylation. The original values of the sensitivities are present Table S3
doi:10.1371/journal.pone.0000936.g005
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response of Smad2 phosphorylation is observed (Figure 6F) with
the combination of a weak inhibition of clathrin dependent
endocytosis and a strong non-clathrin dependent endocytosis (a
high ratio of clathrin to non-clathrin dependent endocytosis rate).
Therefore, the TGF-b signal response is regulated by the balance
between the strength of signal initiation from clathrin dependent
endocytosis and the strength of negative feedback in the venue of
non-clathrin mediated endocytosis.
Recently Vilar et al. proposed a concise computational model of
signal processing in TGF-b superfamily ligand-receptor network
[16]. This work indicates that the key quantity that determines the
qualitative behavior of the pathway is the ratio of the constitutive
to the ligand-induced rate of receptor degradation (CIR,
constitutive-to-induced degradation ratio). Low CIR causes
a transient increase of signal activity that returns to pre-stimulus
levels. On the contrast, high CIR produces a permanently elevated
level of signal activity. The concept of CIR refers to the rates of
two degradations process rather than the simple expression of the
degrading rate constants. This conclusion is affirmed by our
analysis of the balance between clathrin dependent endocytosis
versus non-clathrin mediated endocytosis. Our model shows the
TGF-b signal response is regulated by the ratio of clathrin to non-
clathrin endocytosis rate. On the other hand, the concise model
doesn’t distinguish the receptors in early endosomes and in
caveolar lipid-raft. For ligand-induced degradation of receptors,
the concise model simply regards the processes of the non-clathrin
dependent internalization, recycling and the degradation of the
receptors in caveolar lipid-raft as one-step of ligand induced
receptor degradation at cell surface. Therefore, the control role of
CIR ratio proposed in the concise model is consistent with
regulation role of the clathrin to non-clathrin endocytosis rate ratio
in the comprehensive model of this work.
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Figure 6. Computational simulations of the time course of nuclear phosphorylated Smad2 by the inhibition of different receptor endocytosis in
1000 parameter sets estimated by constraint-based modeling method. The red lines refer the simulations for the parameter values listed in Table 1.
Blue lines correspond to the 1000 parameter sets with the estimated parameter values listed in the Table S1. (A) Same parameter values as those in
parameter sets with the exception that clathrin dependent internalization rate constant is decreased by a factor of 10: kiEE=0.033 min
21. (B) Same
parameters values as those in parameter sets. (C) Same parameter values as those in parameter sets with the exception that non-clathrin dependent
internalization rate constant is decreased by a factor of 10: kiCave=0.033 min
21. (D) Same parameter values as those in parameter sets with the
exception that kiEE is decreased by a factor of 10 and kiCave is decreased by a factor of 2: kiEE=0.033 min
21, kiCave=0.165 min
21. (E) Same parameter
values as those in parameter sets with the exception that kiEE and kiCave are decreased by a factor of 10: kiEE=0.033 min
21, kiCave=0.033 min
21. (F)
Same parameter values as those in parameter sets with the exception that kiEE is decreased by a factor of 2 and kiCave is decreased by a factor of 10:
kiEE=0.165 min
21, kiCave=0.033 min
21.
doi:10.1371/journal.pone.0000936.g006
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